In summary, we demonstrate that RAD9 can regulate NEIL1 at the transcriptional level in human prostate cancer cells, while in mouse ES cells Rad9 impacts on Neil1 protein levels by controlling proteasomal degradation. Here, RAD9A is linked to prostate carcinoma.